Year: 2021

Englewood Cliffs, NJ, Nov. 11, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today reported its financial results for the third quarter 2021 and gave an update on recent progress in its business. Operating HighlightsEntered sponsored research agreement with Columbia University to develop psychedelic therapeutics for Alzheimer’s Disease and received an option to license assets currently under development UMB awarded notice of allowance from the U.S. Patent and Trademark Office for central nervous system homing peptide patent on Silo’s licensed technology Zylo Therapeutics and Silo Pharma’s joint venture received DEA Approval to advance the Patented Z-Pod technology to deliver ketamine Advancement of sponsored research...

Appointment Part of Apollo’s Continued Buildout in Japan and Asia Pacific Region NEW YORK, Nov. 11, 2021 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Toby Myerson has been named as a Senior Advisor to Apollo Japan. Myerson is a veteran of the legal and finance industry with a long history of doing business in Japan, including building the Japan practice for Paul, Weiss, Rifkind, Wharton & Garrison LLP. Myerson joins Apollo as the firm continues to grow its asset management and retirement services business in Japan and the broader Asia Pacific region The addition of Toby is another step in Apollo’s recent expansion in Japan. This year Apollo’s private equity business has completed or announced two significant and complex corporate carveouts in Japan – one with Mitsubishi Chemical and another with Showa Denko –...

– Live moderated video webcast discussion among members of management and ADHD and abuse expert, Stephen V. Faraone, Ph.D., on Thursday, November 18th at 3:00 PM ET PHILADELPHIA, PA, Nov. 11, 2021 (GLOBE NEWSWIRE) — Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment of central nervous system (CNS) disorders, today announced that David Baker, President and Chief Executive Officer, and Timothy Whitaker, M.D., Chief Medical Officer of Vallon, will participate in the Virtual Investor Roundtable Event on Thursday, November 18, 2021 at 3:00 PM ET. Joining the Company’s management team for the roundtable discussion will be Stephen V. Faraone, Ph.D., Distinguished...

SAN DIEGO, Nov. 11, 2021 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies London Virtual Healthcare Conference, being held November 18-19, 2021. The fireside chat will be available on-demand beginning at 3:00 AM Eastern Time on Thursday, November 18, 2021, in the Investors section on the Company’s website at www.traconpharma.com. About TRACON TRACON develops targeted therapies for...

ATHENS, Greece, Nov. 11, 2021 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today that it will release its financial results for the third quarter ended September 30, 2021 on Tuesday, November 16, 2021 before market opens in New York. On the same day, November 16, 2021 at 10:00 a.m. Eastern Time, the Company’s management will host a conference call and webcast to discuss the results. Conference Call details:Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 1 (877) 553-9962 (US Toll Free Dial In), 0(808) 238-0669 (UK Toll Free Dial In) or +44 (0) 2071 928592 (Standard International Dial In). Please quote “Euroseas” to the operator. Audio...

SAN DIEGO, Nov. 11, 2021 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that Todd R. Nelson, PhD, the company’s chief executive officer, will present virtually at the 12th Annual Jefferies London Healthcare Conference. The pre-recorded presentation will be available on Thursday, November 18 at 5:00 pm Greenwich Mean Time / 12:00 pm Eastern time / 9:00 am Pacific time. The presentation can be accessed through a link on the investors section of Codex DNA’s website at https://ir.codexdna.com. An archived replay of the webcast will be available for 30 days following the event. About Codex DNACodex DNA is empowering scientists with the ability to create novel, synthetic biology-enabled solutions for many of humanity’s greatest challenges. As inventors of...

ROCKAWAY, NJ, Nov. 11, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will be available for virtual one-on-one meetings at the Canaccord Genuity MedTech & Diagnostics Forum. The conference is taking place virtually November 18, 2021. Details are as follows: Canaccord Genuity MedTech & Diagnostics Forum:Date: Thursday, November 18, 2021Event: One-on-one meetings Please contact your Canaccord Genuity representative if interested in arranging a one-on-one meeting with electroCore management during the event. About electroCore, Inc.electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform,...

SAN DIEGO, CA and TAICANG, SUZHOU, China, Nov. 11, 2021 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, today announced that Dr. Zheng Wei, Co-Founder & CEO, and Dr. Selwyn Ho, Chief Business Officer, will be participating in fireside chats at the following conferences:Jefferies London Healthcare ConferenceThe fireside chat will be available to view on-demand beginning Thursday, November 18 at 8:00 a.m. GMT / 3:00 a.m. ET.33rd Annual Piper Sandler Healthcare ConferenceThe fireside chat will be available to view on-demand beginning Monday, November 22 at 10:00...

Freshservice unified incident response management with AI-enhanced alerting enables any business to anticipate service disruption and minimize impact LAS VEGAS and SAN MATEO, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) — Freshworks Inc. (NASDAQ: FRSH), a leading software company empowering businesses to delight their customers and employees, today at its Refresh conference unveiled new Freshservice® capabilities that mark the company’s move deeper into the $34 billion IT Operations Management (ITOM) market1. Affordable and easy-to-use, Freshservice’s unified incident response management with AI-enhanced alerting enables any business to anticipate service disruption and minimize impact. “In a world of hybrid working environments with distributed IT teams, the need for systems that ensure service availability has never been higher,” said...

MONTREAL, Nov. 11, 2021 (GLOBE NEWSWIRE) — Earth Alive Clean Technologies Inc. (TSXV: EAC) (“Earth Alive” or the “Company”), a Canadian soil health company that develops and manufactures advanced microbial technology products, this morning reported results for the three-month and nine-month periods ended September 30, 2021. All financial information herein is in Canadian dollars unless otherwise noted. Business HighlightsRevenues after nine months already higher than full-year 2020 levels.US$180,000 Sale of Soil Activator(TM) to new customer in California announced and completed during the third quarter.Further follow-on US$500,000 ea1TM purchase order announced on September 9, 2021, the sixth consecutive order since November 2018 by this customer for its mine located in Mexico.Nikolaos Sofronis appointed as President...